antipsychotics

schizophrenia bipolar disorder neuropsychiatry

Pharma

BMS partner Zai Lab eyes China filing for KarXT after trial win

Following a China-based schizophrenia trial win, Bristol Myers partner Zai Lab is moving fast to expand the global reach of novel antipsychotic KarXT.

Fraiser Kansteiner Oct 29, 2024 1:59pm

A concept image to illustrate mental health medications Models of a pink brain and two white pills which are about the size

Intra-Cellular moves closer to Caplyta depression expansion

Apr 16, 2024 2:27pm

Rovi wins FDA nod to make Moderna's COVID shot at Spanish plant

Feb 28, 2024 11:22am

Teva taps Royalty to bankroll long-acting schizophrenia drug

Nov 13, 2023 11:40am

A puzzle of the brain with one missing piece

Intra-Cellular's Caplyta posts sweeping win in depression trial

Mar 29, 2023 11:30am

Acadia's Nuplazid gets second FDA complete response letter

Aug 5, 2022 11:26am